Mainz Biomed Stock (NASDAQ: MYNZ) stock price, news, charts, stock research, profile.
You can purchase shares of Mainz Biomed (NASDAQ:MYNZ) through any online brokerage.
Other companies in Mainz Biomed’s space includes: Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), Cellectar Biosciences (NASDAQ:CLRB), Imunon (NASDAQ:IMNN) and Can Fite Biofarma (AMEX:CANF).
Mainz Biomed has a consensus price target of $12.50.
The stock price for Mainz Biomed (NASDAQ: MYNZ) is $5.8999 last updated February 21, 2025 at 5:24 PM EST.
There are no upcoming dividends for Mainz Biomed.
Mainz Biomed’s FY earnings are confirmed for Tuesday, April 15, 2025.
There is no upcoming split for Mainz Biomed.
Mainz Biomed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.